Synergistic antibacterial effect against S. Aureus in combination with amoxicillin using fluconazole nanoparticles studied under atomic force microscopy Online publication date: Thu, 04-Jan-2024
by Dania Ahmed; Samina Perveen; Muhammad Raza Shah; Farid Ahmed
International Journal of Nanoparticles (IJNP), Vol. 15, No. 1, 2023
Abstract: COVID-19 patients are increasing day by day. The risk of bacteria-virus co-infection also escalates. Antibiotic resistance caused by pathogenic bacteria has become a major health challenge these days. The key objective was to examine the antibacterial effects of Fluconazole coated silver nanoparticles (Ful-AgNPs) in combination with amoxicillin against bacteria that show resistance to amoxicillin. Here we report quick, and feasible synthetic procedure for the preparation of Ful-AgNPs. Characterisation of nanoparticles was performed by employing Uv, FTIR, and AFM techniques. The size of Ful-AgNPs found in the range from 9-18 nm. Fractional inhibitory concentration index showed synergistic interaction of Ful-AgNPs with amoxicillin with effective inhibitory values found to be 25-50 μg while MIC for amoxicillin alone was found to be 75 μg. Bioassay conducted via AFM along with classical bioassay that supports the synergistic effect of Ful-AgNPs on the antibacterial activity of amoxicillin. Synthesised nanoparticles have found nontoxic against human mononuclear macrophages.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanoparticles (IJNP):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com